china is host to 70 percent of all car cell therapy trials registered in 2017 and the first four months of 2018 (150 out of 214)...: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".
schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.".